» Articles » PMID: 7730635

IL-12 is Required for Natural Killer Cell Activation and Subsequent T Helper 1 Cell Development in Experimental Leishmaniasis

Overview
Journal J Immunol
Date 1995 May 15
PMID 7730635
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

Infection of mice with the protozoan Leishmania major is an established in vivo model for the definition of factors that contribute to CD4+ T helper cell subset development. In the current study, a central role for IL-12 in directing both the innate and adaptive immune responses to L. major is established. We show that in vivo neutralization of IL-12 eliminates the NK cell cytotoxic response and IFN-gamma production by lymph node cells from 2-day L. major-infected C3H mice. Moreover, anti-IL-12 treatment abrogated Th1 cell development and enhanced Th2 cell development. Consistent with these results, elevated IL-12 p40 production and an increase in the number of IL-12 p40-producing cells were observed within 1 day of infection in C3H mice. Because BALB/c mice lack an early NK cell response or a Th1-type immune response after L. major infection, we investigated the possibility that they had a defect in the ability to produce IL-12. Surprisingly, L. major infection stimulated IL-12 p40 production in BALB/c mice early after infection. Further studies suggest that BALB/c mice are unable to generate an early IFN-gamma response because of the simultaneous production of IL-12 and cytokines that inhibit IL-12 function, such as TGF-beta, IL-4, and IL-10. Together, these data show that IL-12 regulates the immune response to L. major, but that even when IL-12 is induced, Th1 cell development may be interrupted by simultaneous production of inhibitory cytokines.

Citing Articles

-the struggles and battles of innate-like effector T lymphocytes with microbes.

Joyce S, Okoye G, Driver J Front Immunol. 2023; 14:1117825.

PMID: 37168859 PMC: 10165076. DOI: 10.3389/fimmu.2023.1117825.


Bleomycin-Induced Lung Injury Increases Resistance to Influenza Virus Infection in a Type I Interferon-Dependent Manner.

Seo S, Jeong J, Baek B, Choi J, Choi Y, Ko H Front Immunol. 2021; 12:697162.

PMID: 34484196 PMC: 8416411. DOI: 10.3389/fimmu.2021.697162.


Potential biomarkers of immune protection in human leishmaniasis.

Nateghi Rostami M, Khamesipour A Med Microbiol Immunol. 2021; 210(2-3):81-100.

PMID: 33934238 PMC: 8088758. DOI: 10.1007/s00430-021-00703-8.


Host-Directed Therapies for Cutaneous Leishmaniasis.

Novais F, Farias Amorim C, Scott P Front Immunol. 2021; 12:660183.

PMID: 33841444 PMC: 8032888. DOI: 10.3389/fimmu.2021.660183.


Pathogenesis of Viral Hepatitis-Induced Chronic Liver Disease: Role of Extracellular Vesicles.

Lim H, Jeffrey G, Ramm G, Soekmadji C Front Cell Infect Microbiol. 2020; 10:587628.

PMID: 33240824 PMC: 7683521. DOI: 10.3389/fcimb.2020.587628.